SCHEMBL5840913

SCHEMBL5840913

CC(=O)N[C@@H]1[C@@H](OCc2ccccc2)O[C@H](COCc2ccccc2)[C@@H](F)[C@@H]1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.49
▸ TP53 P04637 2/20 0.49
▸ MDM2 Q00987 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MDM4 O15151 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ HSP90AB1 P08238 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ NT5E P21589 1/20 0.45
▸ PTPN1 P18031 6/20 0.44
▸ CDC25B P30305 5/20 0.44
▸ SSTR4 P31391 2/20 0.43
▸ PTPN2 P17706 2/20 0.43
▸ PTPN6 P29350 2/20 0.43
▸ PTPN11 Q06124 2/20 0.43
▸ SSTR1 P30872 1/20 0.43
▸ SSTR2 P30874 1/20 0.43
▸ SSTR3 P32745 1/20 0.43
▸ SSTR5 P35346 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5840906 1.00 POLB (0.49) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL15514084 0.90 TP53 (0.55) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL16967451 0.90 TP53 (0.55) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL5840884 0.90 TP53 (0.55) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL5840927 0.90 TP53 (0.55) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL13491599 0.88 POLB (0.52) POLBTP53MDM2L3MBTL1MDM4
SCHEMBL5840823 0.88 SSTR5 (0.52) POLBTP53MDM2L3MBTL1SSTR4
SCHEMBL22053387 0.88 SSTR5 (0.52) POLBTP53MDM2L3MBTL1SSTR4
SCHEMBL5841004 0.88 SSTR5 (0.52) POLBTP53MDM2L3MBTL1SSTR4
SCHEMBL5840925 0.88 SSTR5 (0.52) POLBTP53MDM2L3MBTL1SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098195-B2 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells HEALTH RESEARCH, INC. (US) 2006-08-29 — — US disclosed
US-20030148997-A1 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030148997-A1 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells FUT5, FUT6, OGT POLB 3533/4885TP53 3160/4885MDM2 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback